Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Income from Continuing Operations: 2009-2024

Historic Income from Continuing Operations for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to -$99.1 million.

  • Pediatrix Medical's Income from Continuing Operations rose 26884.93% to $71.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.2 million, marking a year-over-year increase of 16389.36%. This contributed to the annual value of -$99.1 million for FY2024, which is 6399.98% down from last year.
  • According to the latest figures from FY2024, Pediatrix Medical's Income from Continuing Operations is -$99.1 million, which was down 6399.98% from -$60.4 million recorded in FY2023.
  • In the past 5 years, Pediatrix Medical's Income from Continuing Operations ranged from a high of $108.0 million in FY2021 and a low of -$99.1 million during FY2024
  • Moreover, its 5-year median value for Income from Continuing Operations was -$9.6 million (2020), whereas its average is $220400.0.
  • As far as peak fluctuations go, Pediatrix Medical's Income from Continuing Operations surged by 122721.29% in 2021, and later crashed by 19716.27% in 2023.
  • Annual analysis of 5 years shows Pediatrix Medical's Income from Continuing Operations stood at -$9.6 million in 2020, then skyrocketed by 1227.21% to $108.0 million in 2021, then tumbled by 42.43% to $62.2 million in 2022, then plummeted by 197.16% to -$60.4 million in 2023, then plummeted by 64.0% to -$99.1 million in 2024.
  • Its Income from Continuing Operations stands at -$99.1 million for FY2024, versus -$60.4 million for FY2023 and $62.2 million for FY2022.